U.S. Auto Stock News

Analyst upgrades have put Par Pacific Holdings (PARR) firmly on watch for many investors, as higher revenue and earnings forecasts focus attention on its Hawaii operations and the impact of regulatory exemptions. See our latest analysis for Par Pacific Holdings. At a share price of $62.77, Par Pacific’s 30 day share price return of 16.63% and 90 day share price return of 70.11% sit alongside a very large 1 year total shareholder return of 359.85%. This points to strong recent momentum and a...

Class action lawsuits and auditor concerns have pushed Lufax Holding (NYSE:LU) into the spotlight after its former auditor said investors should not rely on the company’s 2022 and 2023 financial statements. See our latest analysis for Lufax Holding. The recent auditor dispute and wave of class action filings have coincided with a sharp loss of momentum, with a 30.11% year to date share price decline and a 91.17% five year total shareholder return loss highlighting prolonged weakness, despite...

Earlier this month, Diamondback Energy, Inc. launched cash tender offers to repurchase any and all of its 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052, with pricing determined by a fixed spread over a long-dated U.S. Treasury and settlement expected around April 13, 2026. This move highlights Diamondback’s active balance sheet management as it seeks to reshape its long-term debt profile and interest obligations through early retirement of outstanding notes. We’ll now examine...

Over the past few days, several major Wall Street firms, including Wells Fargo and UBS, have reaffirmed neutral ratings on Molson Coors Beverage while adopting a more cautious stance on its outlook. This shift reflects a broader cooling of analyst confidence in the company’s near-term prospects, despite its position as a key North American beer producer. Next, we’ll examine how this broader analyst caution toward Molson Coors’ near-term prospects could reshape its longer-term investment...

Why XPO’s Recent Attention Is Catching Investor Interest Fresh commentary on XPO (XPO) centers on efforts to improve service quality, business mix, and pricing, alongside a rise in hedge fund ownership, which has drawn investors back to the freight carrier. See our latest analysis for XPO. The recent focus on service quality and mix comes as XPO’s share price return has been strong, with a 45.58% 3 month share price return and a very large 3 year total shareholder return. This suggests...

AGNC Investment Corp. previously announced that its Board of Directors declared a cash dividend of US$0.12 per common share for April 2026, payable on May 11, 2026 to shareholders of record as of April 30, 2026. This latest monthly dividend declaration underlines AGNC’s emphasis on recurring income for shareholders, supported by its large Agency mortgage-backed securities portfolio and focus on government-guaranteed assets. Next, we’ll explore how this reaffirmed US$0.12 monthly dividend...

Why Piper Sandler Companies (PIPR) is in focus now Piper Sandler Companies (PIPR) is back on investor radars after reporting 2025 growth across advisory, equities institutional brokerage, public finance, and fixed income, along with a four-for-one stock split completed in March 2026. See our latest analysis for Piper Sandler Companies. The recent 1 month share price return of 18.27% and 7 day gain of 7.25% to US$83.47 contrast with a 90 day share price return of a 7.72% decline. At the same...

SiteOne Landscape Supply recently saw UBS reduce its analyst rating from "Buy" to "Neutral," while the company also announced upcoming first-quarter 2026 results and leadership changes in its strategy and development team. The elevation of Daniel Laughlin, a long-time corporate development leader with extensive M&A experience and RSU-based incentives, highlights how SiteOne is tying succession planning and growth initiatives closely to shareholder alignment. Next, we'll examine how UBS's...

In recent days, Atour Lifestyle Holdings reported a fourth-quarter earnings beat that pointed to stronger-than-expected business momentum, coinciding with easing geopolitical tensions after a U.S.-Iran ceasefire that supported travel and consumer names. An interesting aspect is how this combination of robust operating performance and lower oil-related macro risk has drawn in both fundamental and technically focused investors eyeing the company’s operating profile. We’ll now examine how this...

Regions Financial (RF) is back in focus as investors look ahead to its April 17 earnings release, with expectations for year-over-year growth in both revenue and earnings, as well as attention on its relatively high dividend yield. See our latest analysis for Regions Financial. Regions Financial’s share price has moved higher over the past month, with a 10% 30 day share price return, while the 1 year total shareholder return of 51.11% suggests investors have been rewarding the bank’s earnings...

Why Perimeter Solutions (PRM) Is Back on Investor Radars Perimeter Solutions (PRM) has drawn fresh attention after reporting 2025 sales growth of 16% and spotlighting momentum in its specialty products segment, alongside a US$685 million purchase of Medical Manufacturing Technologies. See our latest analysis for Perimeter Solutions. The share price has moved higher over the past month, with a 1 month share price return of 11.95%. However, the year to date share price return of 7.38% and 90...

AST SpaceMobile (ASTS) reported very large year over year revenue growth to US$70.9 million in the fourth quarter of 2025. The company also updated investors on its commercial satellite launch timeline and BlueBird constellation rollout targets. See our latest analysis for AST SpaceMobile. The latest quarterly update, including very large revenue growth and a clearer satellite rollout schedule, comes after a 9.91% 1 month share price return and a 13.69% year to date share price return. The 1...

Earlier this month, Merck announced positive Phase 3 data for its investigational oral PCSK9 inhibitor enlicitide and secured European Union approval for KEYTRUDA in combination with paclitaxel, with or without bevacizumab, for certain adults with platinum-resistant ovarian, fallopian tube or primary peritoneal carcinoma whose tumors express PD-L1. These developments extend Merck’s reach in both cardiovascular and oncology care, potentially diversifying its product mix as it prepares for...

StoneX Group (SNEX) recently announced a partnership with The Pathfinder Group to plug its global payments infrastructure into Pathfinder’s WITS wire platform, giving more financial institutions access to institutional-grade cross-border payments. See our latest analysis for StoneX Group. The partnership news comes after a strong run in the shares, with a 34.6% 30 day share price return and a 43.1% year to date share price return, while the 5 year total shareholder return of 375.1% points to...

Recent trading in Tencent Music Entertainment Group (NYSE:TME) options has shown unusually high implied volatility. This points to expectations of sharp share price swings, while analyst sentiment on the stock and sector remains cautious. See our latest analysis for Tencent Music Entertainment Group. The latest share price of $9.36 sits against a 30 day share price return of 34.04% and a year to date share price return of 47.59%, while the 1 year total shareholder return of 21.48% contrasts...

Broadridge Financial Solutions (BR) has moved deeper into digital assets, extending its governance platform to cover tokenized securities and reporting very large Distributed Ledger Repo volumes, which puts its blockchain based post trade capabilities in sharper investor focus. See our latest analysis for Broadridge Financial Solutions. Despite strong recent news around digital assets and an earnings beat, Broadridge’s 30 day share price return of 15.25% and year to date share price return of...

In April 2026, Vir Biotechnology announced that Executive Vice President and Chief Medical Officer Mark Eisner will step down on April 24, 2026, while the company continues advancing its Bispecific T-Cell engager programs in oncology and infectious diseases. At the same time, Vir’s recently completed collaboration with Astellas, built on positive Phase 1 prostate cancer data, has strengthened its funding base for upcoming clinical trials and highlighted the importance of effective leadership...

Colgate-Palmolive triggered stock overview Colgate-Palmolive (CL) has recently come into focus as investors reassess consumer staples after mixed share performance over the past year, with the stock closing at US$84.34 and longer term returns varying by timeframe. See our latest analysis for Colgate-Palmolive. Recent trading has been choppy, with a 1 day share price return of a 2.0% decline and a 30 day share price return of a 5.1% decline. However, year to date the share price return is 8.6%...

In recent days, several major Wall Street firms, including Goldman Sachs, Morgan Stanley, UBS, TD Cowen, Barclays, and Jefferies, reiterated ratings on Raymond James Financial while resetting their views on the company. At the same time, increased insider selling by senior executives has added a layer of caution to how the market interprets Raymond James Financial’s near-term prospects. Next, we’ll examine how this wave of cautious analyst ratings and insider selling may influence Raymond...

In early April 2026, International Seaways extended its shareholder rights plan to April 8, 2029 and lifted the plan’s purchase price to US$95, reinforcing protections against unsolicited takeover efforts. This move tightens control over potential ownership changes and could meaningfully influence how International Seaways balances capital allocation, corporate control, and long-term governance priorities. We’ll now examine how extending the shareholder rights plan to 2029 could influence...

In early April 2026, Liberty Energy Inc. set April 22 for the release of its first-quarter 2026 results and outlined an investor call the following day led by CEO Ron Gusek and CFO Michael Stock, while analysts and research platforms highlighted concerns about valuation and insider selling over the prior three months. Despite previously strong revenue results and continued communication efforts, Liberty Energy now faces heightened scrutiny as some observers flag the stock as significantly...

In recent days, Palomar Holdings has drawn fresh attention from Wall Street as analysts reaffirmed favorable ratings, highlighted its underwriting performance, and pointed to strong institutional interest in the specialty insurer. At the same time, governance updates, insider share sale disclosures, and the closing of a new US$450,000,000 credit facility provide investors with additional context on how Palomar is managing risk, growth, and executive incentives. With analysts reinforcing...

In the past quarter, Conagra Brands reported third‑quarter sales of US$2,787.8 million, up net income to US$199.8 million, and maintained a quarterly dividend of US$0.35 per share payable on June 3, 2026. Despite stronger quarterly earnings, the company posted a nine‑month net loss of US$299.3 million alongside several analyst downgrades reflecting concerns about sales pressure and costs. Against this backdrop of higher quarterly profitability but a nine‑month loss, we’ll explore how renewed...

Sabine Royalty Trust recently reported April 2026 production results, with oil volumes of 44,645 bbls and gas volumes of 885,409 Mcf, both slightly below the prior month, and declared a monthly cash distribution of US$0.324970 per unit payable on April 29, 2026. This combination of updated production data and a confirmed April payout gives investors a clearer snapshot of the trust’s current income profile. We’ll now look at how the latest monthly distribution declaration shapes Sabine...